Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting

NCT05380063 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2300

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronary Artery Disease
Coronary Artery Bypass Grafting
Dual Antiplatelet Therapy
Bleeding
Myocardial Infarction
Myocardial Ischemia
Angina Pectoris

Interventions

DRUG: De-escalated Dual Antiplatelet Therapy
DRUG: Dual Antiplatelet Therapy

Sponsor

China National Center for Cardiovascular Diseases